CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:MedicinalProductDefinition ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "Cuprior-150mg-Filmcoatedtablet"] ; #
fhir:meta [
( fhir:profile [
fhir:v "http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition"^^xsd:anyURI ;
fhir:link <http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition Cuprior-150mg-Filmcoatedtablet</b></p><a name=\"Cuprior-150mg-Filmcoatedtablet\"> </a><a name=\"hcCuprior-150mg-Filmcoatedtablet\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-idmp-medicinalproductdefinition.html\">IDMP MedicinalProductDefinition</a></p></div><p><b>CH - SMC Authorized Dose Form</b>: <span title=\"Codes:{http://standardterms.edqm.eu 10221000}\">Film-coated tablet</span></p><p><b>CH - EPL Full Limitation Text</b>: CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.</p><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID</code>/CH-7640109110007-6771901</p><p><b>indication</b>: </p><div><p>Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.</p>\n</div><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}\">Medicinal product subject to medical or veterinary prescription (B)</span></p><p><b>additionalMonitoringIndicator</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator 756005001003}\">No Warning</span></p><p><b>pediatricUseIndicator</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator 756005003001}\">Authorised for the treatment in children</span></p><p><b>classification</b>: <span title=\"Codes:{http://www.whocc.no/atc L01EX13}\">gilteritinib</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category 756005021001}\">NA KAS art. 12 para. 5 TPLO</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode 756005004001}\">Synthetic</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type 756001003002}\">Originator product</span></p><p><b>attachedDocument</b>: </p><ul><li><a href=\"DocumentReference-DocRef-FI-Cuprior.html\">DocumentReference: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber#123456789-initial submission-Example-abc-123; status = current; type = Fachinformation; date = 2020-09-01 00:00:00+0000</a></li><li><a href=\"DocumentReference-DocRef-PI-Cuprior.html\">DocumentReference: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber#123456789-initial submission-Example-abc-321; status = current; type = Patienteninformation; date = 2020-09-01 00:00:00+0000</a></li></ul><blockquote><p><b>name</b></p><p><b>productName</b>: Cuprior 150 mg, Filmtabletten</p><p><b>type</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type SMC}\">Zugelassener Arzneimittelname</span></p><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{urn:iso:std:iso:3166 CH}\">Switzerland</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 de-CH}\">German (Switzerland)</span></td></tr></table></blockquote></div>"^^rdf:XMLLiteral
] ; #
fhir:extension ( [
fhir:url [ fhir:v "http://fhir.ch/ig/ch-epl/StructureDefinition/authorizedDoseForm"^^xsd:anyURI ] ;
fhir:value [
a fhir:CodeableConcept ;
( fhir:coding [
fhir:system [ fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ] ;
fhir:code [ fhir:v "10221000" ] ;
fhir:display [ fhir:v "Film-coated tablet" ] ] ) ]
] [
fhir:url [ fhir:v "http://fhir.ch/ig/ch-epl/StructureDefinition/fullLimitationText"^^xsd:anyURI ] ;
fhir:value [
a fhir:string ;
fhir:v "CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden." ]
] ) ; #
fhir:identifier ( [
fhir:system [ fhir:v "http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID"^^xsd:anyURI ] ;
fhir:value [ fhir:v "CH-7640109110007-6771901" ]
] ) ; #
fhir:indication [ fhir:v "Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie."] ; #
fhir:legalStatusOfSupply [
( fhir:coding [
fhir:system [ fhir:v "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply"^^xsd:anyURI ] ;
fhir:code [ fhir:v "756005022003" ] ;
fhir:display [ fhir:v "Medicinal product subject to medical or veterinary prescription (B)" ] ] )
] ; #
fhir:additionalMonitoringIndicator [
( fhir:coding [
fhir:system [ fhir:v "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator"^^xsd:anyURI ] ;
fhir:code [ fhir:v "756005001003" ] ;
fhir:display [ fhir:v "No Warning" ] ] )
] ; #
fhir:pediatricUseIndicator [
( fhir:coding [
fhir:system [ fhir:v "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator"^^xsd:anyURI ] ;
fhir:code [ fhir:v "756005003001" ] ;
fhir:display [ fhir:v "Authorised for the treatment in children" ] ] )
] ; #
fhir:classification ( [
( fhir:coding [
fhir:system [ fhir:v "http://www.whocc.no/atc"^^xsd:anyURI ] ;
fhir:code [ fhir:v "L01EX13" ] ] )
] [
( fhir:coding [
fhir:system [ fhir:v "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category"^^xsd:anyURI ] ;
fhir:code [ fhir:v "756005021001" ] ;
fhir:display [ fhir:v "NA KAS art. 12 para. 5 TPLO" ] ] )
] [
( fhir:coding [
fhir:system [ fhir:v "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode"^^xsd:anyURI ] ;
fhir:code [ fhir:v "756005004001" ] ;
fhir:display [ fhir:v "Synthetic" ] ] )
] [
( fhir:coding [
fhir:system [ fhir:v "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type"^^xsd:anyURI ] ;
fhir:code [ fhir:v "756001003002" ] ;
fhir:display [ fhir:v "Originator product" ] ] )
] ) ; #
fhir:attachedDocument ( [
fhir:reference [ fhir:v "DocumentReference/DocRef-FI-Cuprior" ]
] [
fhir:reference [ fhir:v "DocumentReference/DocRef-PI-Cuprior" ]
] ) ; #
fhir:name ( [
fhir:productName [ fhir:v "Cuprior 150 mg, Filmtabletten" ] ;
fhir:type [
( fhir:coding [
fhir:system [ fhir:v "http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type"^^xsd:anyURI ] ;
fhir:code [ fhir:v "SMC" ] ;
fhir:display [ fhir:v "Zugelassener Arzneimittelname" ] ] ) ] ;
( fhir:usage [
fhir:country [
( fhir:coding [
fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
fhir:code [ fhir:v "CH" ] ;
fhir:display [ fhir:v "Switzerland" ] ] ) ] ;
fhir:language [
( fhir:coding [
fhir:system [ fhir:v "urn:ietf:bcp:47"^^xsd:anyURI ] ;
fhir:code [ fhir:v "de-CH" ] ;
fhir:display [ fhir:v "German (Switzerland)" ] ] ) ] ] )
] ) . #
IG © 2023+ Federal Office of Public Health FOPH. Package ch.fhir.ig.ch-epl#1.0.0-ci-build based on FHIR 5.0.0. Generated 2025-09-01
Links: Table of Contents |
QA Report
| Propose a change